Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Curanex Pharmaceuticals Inc Common Stock
Market Cap
$7.03M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.88M
Operating Margin
-5025.53%
TTM Avg
-3024.64%
3Y Avg
-1688.76%
5Y Avg
-1108.68%
Market Cap
$6.76M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.74M
Operating Margin
-9312.55%
TTM Avg
-10684.89%
3Y Avg
-9259.36%
5Y Avg
-8523.06%
Market Cap
$6.72M
Operating Margin
-450.07%
TTM Avg
-699.99%
3Y Avg
-986.00%
5Y Avg
-5433.17%
Market Cap
$6.44M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.34M
Operating Margin
-119.54%
TTM Avg
-108.09%
3Y Avg
-117.27%
5Y Avg
-99.55%
Market Cap
$7.75M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.77M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Curanex Pharmaceuticals Inc Common Stock (CURX) | $7.03M | 0.00% | 0.00% | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -5025.53% | -3024.64% | -1688.76% | -1108.68% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -9312.55% | -10684.89% | -9259.36% | -8523.06% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -450.07% | -699.99% | -986.00% | -5433.17% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biomerica, Inc. (BMRA)vs › | $6.34M | -119.54% | -108.09% | -117.27% | -99.55% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| GT Biopharma, Inc. (GTBP)vs › | $7.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Femasys Inc. (FEMY)vs › | $6.10M | -763.90% | -929.35% | -1043.46% | -924.75% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
